RBx 4638
Alternative Names: ClafrinastLatest Information Update: 20 Nov 2006
At a glance
- Originator Ranbaxy Laboratories
- Class Antiasthmatics
- Mechanism of Action Integrin alpha4beta1 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 04 Dec 2002 No development reported - Preclinical for Asthma in India (PO)
- 11 Apr 2000 ClafrinastTM is available for licensing (http://www.ranbaxy.com/)
- 11 Apr 2000 Preclinical development for Asthma in India (PO)